Now There’s a Painless Cure for the Most Common Cancer Type
The scorching sun is the major reason that skin cancer is the nation’s most common cancer type. But there’s seriously good news — dermatologists can now cure most cases of nonmelanoma skin cancer (basal cell and squamous cell carcinomas) without scalpels, pain, bleeding, infection, surgical scarring or the need for reconstructive surgery. Dermatologists around the country […]
The Chemotherapy Blues: How Depression Impacts Treatment Efficacy
Chemotherapy is a commonly used treatment for cancer patients. It involves the use of strong drugs to kill cancer cells in the body. While it is an effective treatment, chemotherapy can have several side effects that can impact a patient’s physical and mental health. One of the most common side effects is depression. Depression can […]
Women: Take the “Pearl Pledge” For Cervical Cancer Awareness
Staying healthy can be easier when done with a friend. That’s the idea behind the new “Take the Pearl Pledge” program to fight cervical cancer. “Cervical cancer is the second leading cancer in women worldwide. This year in the United States, more than 11,000 women will be diagnosed with cervical cancer, and more than 4,000 […]
6 Takeaways For Cancer Programs From Medicare’s 2023 Proposed Rules
In July 2022, the Centers for Medicare & Medicaid Services (CMS) released its proposed rules for the Medicare program for 2023. These rules have important implications for cancer programs across the United States, and provide insights into the direction of cancer care reimbursement and delivery in the coming years. Here are six key takeaways for […]
How The Pandemic Impacted Cancer Service Volumes, In 8 Graphs
The COVID-19 pandemic has had a significant impact on healthcare systems worldwide, with many resources being diverted to manage the outbreak. One area that has been affected is cancer services, with delays and cancellations of cancer surgeries, diagnostic tests, and screening programs. In this article, we will explore how the pandemic impacted cancer service volumes […]
Investigational Therapy May Change How Urinary Tract Cancer is Treated
The cancer is called upper tract urothelial carcinoma (UTUC). It affects the lining of the kidney and the ureter, the tube that connects the kidney to the bladder. UTUC can be classified as high-grade or low-grade. People diagnosed with the high-grade disease usually must have their kidney, or both their kidney and ureter, removed. Those […]
Clinical Trials Seek Cancer Patients
Despite widespread public awareness campaigns on behalf of the American Association for Cancer Research (AACR), it seems the majority of patients don’t know about the cancer clinical trials available to them. Clinical trials are still the only means to test new cancer treatment and medication, but the AACR says fewer than five percent of cancer patients volunteer. […]
Cancer Program Development Grids
Cancer program development grids are tools used to assess and improve the quality of cancer care services provided by healthcare organizations. These grids provide a framework for the evaluation of the cancer program’s performance across various domains, including patient outcomes, resource utilization, clinical quality, patient experience, and financial viability. Cancer program development grids are particularly […]
Pediatric Cancer Landscape Calls for Global Outreach
Around the world, pediatric cancer survival rates are failing to keep pace with real-life treatment and diagnostic opportunities. Five-year survival rates for children with cancer went from 30 percent in the 1960s to 80 percent in the 2000s, but since then improvements have been sparse. Developing countries, those too often faced with few resources and […]
New Cancer Test Helps Men Reduce Unnecessary Prostate Biopsies
According to the American Cancer Society (ACS), other than skin cancer, prostate cancer is the most common cancer in American men. The ACS estimates that in 2019 there will be approximately 174,650 new cases of prostate cancer and 31,620 deaths. About 1 man in 9 will be diagnosed with prostate cancer during his lifetime. Prostate […]